Na Mee 14, 2025, Hangzhou Testsea Biotechnology Co., Ltd. (nke a na-akpọ "Testsealabs") na Zhejiang hailiangbio Co., Ltd. (nke a na-akpọ "hailiangbio") n'ụzọ iwu kwadoro nkwekọrịta nkwekọrịta nkwekọrịta. Njikọ a bụ iji mee ka mbupụ ahịa nke ngwaahịa exosome nke stem cell na-enweta na ngwọta mgbochi WT1 na mpaghara ndị dị mkpa dị ka Ndịda Ebe Ọwụwa Anyanwụ Eshia, Europe, na Australia.
Ememe mbinye aka a bụ mmalite nke isi ọhụrụ na imekọ ihe ọnụ nke mba abụọ. Zhou Bin, onye isi njikwa nke Testsealabs, kwuru n'oge mmemme ahụ: "Nkwekọrịta a ga-eduzi atụmatụ mmekọrịta mpaghara nke 'Testsealabs in the North, hailiangbio na South China Sea,' na-eguzobe akara ngosi maka ụlọ ọrụ biotech China na-agbasa n'ụwa niile." Dị ka nzọụkwụ dị mkpa na atụmatụ mba ụwa nke Testsealabs, ụlọ ọrụ ahụ na-atụ anya itinye aka na Ndịda Ebe Ọwụwa Anyanwụ Eshia dị ka ihe mmalite na ijikwa ike mmekọrịta nke ụlọ ọrụ abụọ ahụ iji webata ngwa ngwa ngwa ngwa, gụnyere exosomes cell stem na ngwọta mgbochi WT1, na ahịa ụwa.
Dr. Lei Wei, onye isi njikwa nke hailiangbio, mere ka ọ pụta ìhè: "Amatara ikike nka na ụzụ Testsealabs na nchọpụta." A na-atụ anya na mmekorita a ọ bụghị naanị ịgbasa Pọtụfoliyo ngwaahịa anyị kamakwa na-ebuga ngwọta ahụike dị elu na ahịa ndịda Ebe Ọwụwa Anyanwụ Eshia. Anyị nwere obi ike na atụmanya na-ekwe nkwa nke mmekorita a.
N'ikwekọ na nkwekọrịta ahụ, akụkụ abụọ a ga-elekwasị anya na ntụzịaka atụmatụ ndị a:
1. ** Njikọ Mgbasawanye nke Global Markets ***: Leveraging Testsealabs's elu nchọpụta teknụzụ na hailiangbio si zuru ụwa ọnụ ọwa akụrụngwa, na mmekorita ga-elekwasị anya na atọ isi ahịa-Southeast Asia, Europe, na Australia-iji mee ka internationalization nke azuokokoosisi-ewepụtara exosome ngwaahịa na WT1 tumor mgbochi ngwọta.
2. ** Ntọala nke Nchọpụta Technology Innovation Ecosystem ***: Na isi n'ihu nke nkà na ụzụ imekọ ihe ọnụ, abụọ ọzọ ebumnuche "mebie site na nkà na ụzụ ókè na jikọrọ ọnụ guzosie ike ụkpụrụ zuru ụwa ọnụ," na-akwalite multi-akụkụ na omimi mmekorita. A ga-eme ka mmekọrịta dị n'ahịa sikwuo ike site na atụmatụ dị iche iche dị ka mmekorita akara na mgbanwe mmụta mmụta n'oke ala.
3. ** Ngosipụta nke Strategic Uru na Industry Leadership ***: The teknuzu ụkpụrụ na localized ọrụ ụdị co-mepụtara site abụọ ọzọ na-enye a replicable "dual-ike imekọ ihe ọnụ" nlereanya maka Chinese biotech ụlọ ọrụ venturing ná mba ọzọ, na-akwọ ụgbọala na ụlọ ọrụ n'ebe etiti-na-elu ọgwụgwụ nke zuru ụwa ọnụ uru yinye.
Njikọ dị n'usoro a na-anọchi anya ihe dị oke mkpa maka Testsealabs na hailiangbio iji kwalite ike mmekọ yana nweta uru ọ bụla. N'ịga n'ihu, akụkụ abụọ ahụ ga-eguzobe usoro nkwurịta okwu mgbe niile, na-enyocha ọganihu nke mmekorita ha kwa oge, ma hụ na mmezu nke atụmatụ niile dị nke ọma.
Mgbe emume mbinye aka ahụ gasịrị, ndị nnọchi anya ụlọ ọrụ abụọ ahụ sere foto otu ncheta iji gosi oge a dị mkpa. Anyị nwere obi ike na site na nkwonkwo mbọ, mmekorita a ga-etinye ume ọhụrụ n'ime mmepe nke ụlọ ọrụ biopharmaceutical ma na-enye onyinye dị ukwuu na ahụike zuru ụwa ọnụ.
Oge nzipu: Mee-22-2025